Skip to main content

Quality of Life in Pancreatic Cancer

  • Chapter
  • 163 Accesses

Abstract

Pancreatic cancer is well known to have a short duration of survival after diagnosis, and to be relatively resistant to current therapies. When survival is short, quality of life (QOL) assumes great importance, and clinicians should be concerned not only with the biophysical disease process, but with the consequences of illness on the well-being of their patients. Knowledge of the demands that disease brings, not only in terms of physical threats, but also psychological and social consequences, and how the patient copes with their illness, treatment, and care, can only help greater understanding of disease and illness. Consideration of how to improve the quality as well as quantity of life is of paramount importance. It is recognized that QOL assessment is long overdue in pancreatic cancer (1).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Trede M. Treatment of pancreatic carcinoma—the surgeon’s dilemma. Br J Surg 1987; 74:79,80.

    Article  Google Scholar 

  2. Haddock G and Carter DC. Aetiology of pancreatic cancer. BrJ Surg 1990; 77:1159–1165.

    Article  CAS  Google Scholar 

  3. Carter DC. Clinical features and management of carcinoma of the pancreas. Br J Hosp Med 1995; 54:459–464.

    PubMed  CAS  Google Scholar 

  4. Ashton Key M, Hammersley S, Johnson CD. Incidence and mortality of gastric and pancreatic cancer in England and Wales 1961-1988. Gut 1991; 32:A580–A581.

    Google Scholar 

  5. Krech RL and Walsh D. Symptoms of pancreatic cancer. J Pain Symptom Manage 1991; 6:360–367.

    Article  PubMed  CAS  Google Scholar 

  6. Fontham ETH and Correa P. Epidemiology of pancreatic cancer. Surg Clin North Am, 1989; 69:551.

    PubMed  CAS  Google Scholar 

  7. Slevin ML. Quality of life: philosophical question or clinical reality? Br Med J 1992; 305:466–469.

    Article  CAS  Google Scholar 

  8. Fallowfield L. Quality of life: the missing measurement in health care. Souvenir, London, 1990.

    Google Scholar 

  9. World Health Organisation Constitution. WHO Chron 1947; 7:29.

    Google Scholar 

  10. Karnofsky DA, Abelman WH, Craver LF, et al. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948; 1:634–656.

    Article  Google Scholar 

  11. Meeberg GA. Quality of life: a concept analysis. J Adv Nurs 1993; 18:32–38.

    Article  PubMed  CAS  Google Scholar 

  12. Quality of life and clinical trials. Lancet 1995; 346:1–2 (editorial).

    Google Scholar 

  13. Kassa S. Problems in assessing quality of life. J Cancer Care 1993; 2:100–103.

    Google Scholar 

  14. Cella DF. Quality of life: concepts and definitions. J Pain Symptom Manage 1994; 9:186–192.

    Article  PubMed  CAS  Google Scholar 

  15. Gill TM and Feinstein AR. A critical appraisal of the quality of life measurements. JAMA 1994; 272:619–626.

    Article  PubMed  CAS  Google Scholar 

  16. Streiner DL and Norman GR. Health measurement scales: a practical guide to their development and use, 2nd ed., Oxford University Press, Oxford, 1992.

    Google Scholar 

  17. Jaloweic A. Issues in using multiple measures of quality of life. Semin Oncol Nurs 1990; 6:271–277.

    Article  Google Scholar 

  18. Hayden KA, et al. Pitfalls in quality of life assessment. Lessons from a Southwest Oncology Group breast cancer clinical trial. Oncol Nurs Forum 1993; 20:1415–1419.

    CAS  Google Scholar 

  19. Donovan K, Sanson Fisher RW, and Redman S. Measuring quality of life in cancer patients. J Clin Oncol 1989; 7:959–968.

    PubMed  CAS  Google Scholar 

  20. Gill, TM. Quality of life assessment: values and pitfalls. J Royal Soc Med 1995; 88:680–682.

    CAS  Google Scholar 

  21. Watanapa P and Williamson RCN. Surgical palliation for pancreatic cancer: developments during the past two decades. Br J Surg 1992; 79:8–20.

    Article  PubMed  CAS  Google Scholar 

  22. De Wys WD. Weight loss and nutritional abnormalities in cancer patients: incidence, severity and significance. Clin Oncol 1986; 5:251–261.

    Google Scholar 

  23. Kaiser MH, Barkin J, and Maclntyre JM. Pancreatic cancer: assessment of prognosis by clinical presentation. Cancer 1985; 56:397–402.

    Article  Google Scholar 

  24. Lebovits AH and Lefkowitz M. Pain management of pancreatic carcinoma: a review. Pain 1988; 36:1–11.

    Article  Google Scholar 

  25. Kelsen DP. Portenoy RK, Thaler HT, Niedzwiecki D, Passik SD, Tao Y, et al. Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol 1995; 13:748–755.

    PubMed  CAS  Google Scholar 

  26. Passik SD and Breitbart WS. Depression in patients with pancreatic carcinoma. Diagnostic and treatment issues. Cancer 1996; 78:615–626.

    CAS  Google Scholar 

  27. Faulkner A and Maguire P. Talking to cancer patients and their families. Oxford: Oxford Medical, Oxford, 1994.

    Google Scholar 

  28. Dunkel-Schatter C, Feinstein LG, Taylor SE, and Falke RL. Patterns of coping with Cancer. Health Psych 1992; 11:79–87.

    Article  Google Scholar 

  29. Gammon J. Which way out of the crisis? Coping strategies for dealing with cancer. Professional Nurse 1993; May 488–493.

    Google Scholar 

  30. Maguire K. Improving the recognition and treatment of affective disorders in cancer patients. In: Granville-Grasson K (ed), Recent advances in psychiatry, 7th ed. Churchill Livingstone, London, 1992; 15–30.

    Google Scholar 

  31. Ishikawa O, Ohigashi H, Nakaizumi A, et al. Surgical resection of potentially curable pancreatic cancer with improved preservation of endocrine function: further evaluation of intraoperative cytodiagnosis. Hepato-gastroenterology 1993; 40:443–447.

    PubMed  CAS  Google Scholar 

  32. Yasue M, Sakamoto J, Morimoto T, et al. Evaluation of the effect of pancreatic resection in advanced pancreatic cancer with special reference using hospital-free survival as a measure of quality-of-life. Jap J Clin Oncol 1995; 25:37–45.

    CAS  Google Scholar 

  33. Eypasch E, Williams JI, and Wood-Dauphinee S. Gastrointestinal quality of life index; development, validation and application of a new instrument. Br J Surg 1995; 82:216–222.

    Article  PubMed  CAS  Google Scholar 

  34. Pretre R, Huber O, Robert J, Soravia C, Egeli RA, and Rohner A. Results of surgical palliation for cancer of the head of the pancreas and periampullary region. Br J Surg 1992; 79:795–798.

    Article  PubMed  CAS  Google Scholar 

  35. Ebert M, Friess H, Beger HG, and Büchler MW. Role of octreotide in the treatment of pancreatic cancer. Digestion 1994; 55:48–51.

    Article  PubMed  Google Scholar 

  36. Bakkevold KE and Kambestad B. Palliation of pancreatic cancer: a prospective multicentre study. Eur J Surg Oncol 1995; 27:176–182.

    Article  Google Scholar 

  37. Glimelius B, Hoffman K, Graf W, et al. Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol 1995; 6:267–274.

    PubMed  CAS  Google Scholar 

  38. Ballinger AB, McHugh M, Catnach SM, Alstead EM, and Clark MI. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut 1994; 35:467–470.

    Article  PubMed  CAS  Google Scholar 

  39. Luman W, Cull A, Palmer KR. Quality of life following endoscopic stenting for malignant biliary obstruction. Abstract presented at the British Society of Gastroenterology, March, Brighton, 1996.

    Google Scholar 

  40. Lionetto R, Pugliese V, Bruzzi P, Rosso R. No standard treatment is available for advanced pancreatic cancer. Eur J Cancer 1995; 31A: 882–887.

    Article  PubMed  CAS  Google Scholar 

  41. Niezgoda HE and Pater JL. A validation study of the domains of core EORTC quality of life questionnaire. Qual Life Res 1993; 2:319–325.

    Article  PubMed  CAS  Google Scholar 

  42. Sprangers MA, Cull A, Bjordal K, Groenvold M, and Aaronson NK. The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life. Qual Life Res 1993; 2:287–295.

    CAS  Google Scholar 

  43. Ringdal GI and Ringdal K. Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses. Qual Life Res 1993; 2:129–140.

    Article  PubMed  CAS  Google Scholar 

  44. Aaronson NK, Cull A, Kassa S, and Sprangers MG, for the EORTC Study Group on Quality of Life. The EORTC modular approach to quality of life assessment in oncology: an update. In: Spiker B (ed), Quality of life and pharmoeconomics in clinical trials, 2nd ed. Raven, New York, 1995

    Google Scholar 

  45. Strauss A and Corbin J. Basics of qualitative research. Grounded theory procedures and techniques, Sage, London, 1990.

    Google Scholar 

  46. Portenoy RK. Pain and quality of life: clinical issues and implications for research. In: Tchekmedyian NS and Cella DF (eds), Quality of life in oncology practice and research, PRR Dominus, New York, 1991.

    Google Scholar 

  47. Pitt HA. Curative treatment for pancreatic neoplasms. Standard resection. Surg Clin N Am 1995; 75:891–904.

    CAS  Google Scholar 

  48. Maguire P (1985). Barriers to psychological care of the dying. Br Med J 291, 1711–1713.

    Article  CAS  Google Scholar 

  49. Sugarbaker PH, Barosky I, Rosenberg SA, and Gianola FJ. Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery 1982; 91:17–23.

    PubMed  CAS  Google Scholar 

  50. McLeod RS, Taylor BR, O’Connor BI, Greenberg GR, Jeejeebhoy KN, Royall D, and Langer B. Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg 1995; 169:179–185.

    Article  PubMed  CAS  Google Scholar 

  51. Fraser SCA. Quality of life measurement in surgical practice. Br J Surg 1993; 80:163–168.

    Article  PubMed  CAS  Google Scholar 

  52. Lichtenstein DR and Carr-Locke DL Endoscopic palliation for unresectable pancreatic carcinoma. [Review] Surg Clin N Am 1995; 75:969–988.

    PubMed  CAS  Google Scholar 

  53. Palmer KR, Kerr M, Knowles G, Cull A, Carter DC, and Leonard RCF. Chemotherapy prolongs survival in inoperable pancreatic-carcinoma. Br J Surg 1994; 81:882–885.

    Article  PubMed  CAS  Google Scholar 

  54. Jessup JM, Posner M, and Hubeman M. Influence of multi-modality therapy on the management of pancreatic carcinoma. Semin Surg Oncol 1993; 9:27–32.

    Article  PubMed  CAS  Google Scholar 

  55. Waegner DJT, Punt CJA, and Wilke H. Current status and future directions in the perioperative treatment of pancreatic cancer. Ann Oncol 1994; 5(Suppl):S87–S90.

    Article  Google Scholar 

  56. Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged: the index of ADL: a standardised measure of biological and psychosocial function. JAMA 1963; 185:914–919.

    Article  PubMed  CAS  Google Scholar 

  57. Kaplan RM, Bush JW, and Berry CC. Health status types of validity and the index of well being. Health Serv Res 1976; 11:478–507.

    PubMed  CAS  Google Scholar 

  58. Deyo RA, Inui TS, Leninger JD, et al. Physical and psychological functions in rheumatoid arthritis: clinical use of a self-administered instrument. Arch Intern Med 1982; 142:879–882.

    Article  PubMed  CAS  Google Scholar 

  59. Hunt SM, Mckenna SP, McEwan J, et al. A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health 1980; 35:297–300.

    Article  Google Scholar 

  60. Chambers LW, Sackett DL, Goldsmith CH, et al. Development and applications of an index of social function. Health Serv Res 1976; 11:430–441.

    PubMed  CAS  Google Scholar 

  61. Goldberg DP and Williams P. A users guide to the general health questionnaire. Windsor NFER, nelson.

    Google Scholar 

  62. Satoris N. A WHO method for the assessment of health related quality of life. In: Walker SR and Rosser RM (eds) Quality of life assessment: key issues for the 1990s, Klewer, London, 1993; pp. 201–207.

    Google Scholar 

  63. Ware JE, Gandek B, the IQOLA Project Group. The SF-36 health survey: development and use in mental health research and the IQOLA Project. Int J Ment Health 1994; 23:49–73.

    Google Scholar 

  64. Spitzer WO, Dobson AJ, Hall J, et al. Measuring quality of life of cancer patients: a concise QL index for use by physicians. J Chron Dis 1981; 34:585–597.

    Article  PubMed  CAS  Google Scholar 

  65. Osbond ME, Lavin PT, Babyam RK, et al. Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic cell carcinoma. Lancet 1990; 335:994–998.

    Article  Google Scholar 

  66. Schnipper H, Clinch J, McMurray A, and Levitt M. Measuring the quality of life of cancer patients the functional living index: cancer development and validation. J Clin Oncol 1984; 472–483.

    Google Scholar 

  67. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Nat Cancer Inst 1993; 85:365–376.

    Article  PubMed  CAS  Google Scholar 

  68. De Haes JCJM, van Knippenberg FCE, and Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam symptom checklist. Br J Cancer 1990; 62:1034–1038.

    Article  PubMed  Google Scholar 

  69. Priestman TJ and Baum M. Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Linear analogue self assessment (LASA). Lancet 1976; 7:899–901.

    Google Scholar 

  70. Cella DF, Tulskey DS, and Gray G. Functional assessment of cancer therapy (FACT) scale: development and validation of the general measure. J Clin Oncol 1993; 11:570–579.

    PubMed  CAS  Google Scholar 

  71. Zung WWK. Self rating depression scale. Arch Gen Psychiatry 1965; 12:63–70.

    Article  PubMed  CAS  Google Scholar 

  72. Melzack R. The McGill pain questionnaire major properties and scoring methods. Pain 1975; 1:277.

    Article  PubMed  CAS  Google Scholar 

  73. Beck AT, Mendelson M, Mock J, et al. Psychometric properties of the Beck depression inventory: twenty-five years of evaluation. Clin Psych Rev 1988; 8:77–100.

    Article  Google Scholar 

  74. Baker F, Curbow B, and Wingward JR. Role retention and quality of life of bone marrow transplant survivors. Soc Sci Med 1991; 32:697–704.

    Article  PubMed  CAS  Google Scholar 

  75. Morrow GR, Chiarello RJ, and Derogatis LR. A new scale for assessing patients psychological adjustment to medical illness (PAIS). Psych Med 1978; 8:605–610.

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Fitzsimmons, D., Johnson, C.D. (1998). Quality of Life in Pancreatic Cancer. In: Reber, H.A. (eds) Pancreatic Cancer. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-1810-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-1810-4_18

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4612-7294-6

  • Online ISBN: 978-1-4612-1810-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics